Company Profile
Chronicle of Events
Contact Us
New Drug R&D
Production Quality
Commercialization
Global Cooperation
R&D Pipeline
Talent Development Concept
Career Opportunities
After a series of strict and comprehensive reviews and assessment, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (referred to as “Sunshine Guojian”) was awarded the Grade A quality credit unit in the quality credit rating assessment of Shanghai pharmaceutical manufacturing enterprises.
On October 12, 2017, Sunshine Guojian’s YISAIPU was successfully granted the GMP certificate issued by the Mexican Ministry of Health.
On July 25 to 28, 2017, the Zhongzhi QC Team of Stock Solution Workshop C, on behalf of Sunshine Guojian Pharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as “Sunshine Guojian”), attended the 38th National Pharmaceutical Industry Quality Control Circle (QCC) Achievement Presentation and Exchange Meeting. Liu Wanbing, the team representative, published the achievement named “Optimization of Freezing Technology of Stock Solution,” which was awarded the first prize among 588 achievement projects presented on the site from 161 pharmaceutical companies in China.
Sunshine Guojian Pharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as “Sunshine Guojian”) accepted the 5-day comprehensive GMP inspection conducted by the National Food and Drug Administration of Colombia. The review results showed that Sunshine Guojian’s Stock Solution Zone A, Stock Solution B, Preparation Zone I and Preparation Zone III of Antibody Production Lines passed the official GMP certification review in Columbia.
On April 1, 2017, the 30,000L Antibody Production Line Preparation Zone III of Sunshine Guojian Pharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as Sunshine Guojian) was granted the “Certificate of Good Manufacturing Product for Pharmaceutical Products” (Certificate No.: SH20170009, valid until March 2022) by the China Food and Drug Administration.
